Microarray data from chronic myeloid leukemia (CML) samples [46] indicate up-regulation of PRAME and concomitant down-regulation of TRAIL in CML cells in comparison to normal cells. This evidence concerns the gene TNFSF10 and chronic myelogenous leukemia, BCR-ABL1 positive.